Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
mfERG_LAB: Software for processing multifocal electroretinography signals.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Symptom overlap in anxiety and multiple sclerosis.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up.
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
Patient perceptions of multiple sclerosis and its treatment.
Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients.
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
Disease-modifying drugs for multiple sclerosis and JC virus expression.
Pages
« first
‹ previous
…
118
119
120
121
122
123
124
125
126
…
next ›
last »